Anthony G.M. Barrett, FRS, FMedSci
VP Chemistry
Allan M. Cohen, Esq., CPA
Chief Executive Officer
Mark Roffman, PhD
VP Drug Development and Regulatory Affairs
Robert Gottlieb
Advisor, Strategy and Messaging
Eliot Ohlstein, PhD
VP Pharmacologic R&D
Martin D Hynes III, PhD
VP Project Management and Quality Assurance
Board of Directors
Barry A. Berkowitz, PhD
Founder and Chairman
Marc Goldberg, JD, MBA
Managing Partner, BioVentures Investors
Allan M. Cohen, Esq., CPA
Chief Executive Officer
E. Jonathan Soderstrom, PhD
Chief Licensing Advisor, Wilson, Sonsini
